scholarly article | Q13442814 |
P50 | author | Ilan Tsarfaty | Q111524904 |
P2093 | author name string | T. Suzuki | |
G. F. Vande Woude | |||
D. L. Faletto | |||
M. Gonzatti | |||
T. E. Kmiecik | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | proto-oncogene | Q30555 |
P304 | page(s) | 1149-1157 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Evidence for non-covalent clusters of the c-met proto-oncogene product | |
P478 | volume | 7 |
Q27647900 | A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist |
Q34426051 | A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation |
Q47303095 | Activated HGF-c-Met Axis in Head and Neck Cancer |
Q40667298 | Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer. |
Q36595980 | Activating mutations for the met tyrosine kinase receptor in human cancer |
Q42263223 | Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer |
Q37404891 | Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor |
Q27635335 | Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. |
Q36710400 | Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists |
Q36565319 | Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway |
Q34584046 | Dysregulation of Met receptor tyrosine kinase activity in invasive tumors |
Q50977853 | Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling. |
Q35070072 | In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met |
Q33566681 | MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor |
Q38167461 | MET receptor tyrosine kinase as an autism genetic risk factor |
Q53483428 | Molecular mechanism of stomach carcinogenesis. |
Q34236834 | Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET. |
Q34753763 | Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells |
Q38431115 | Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases. |
Q41969702 | Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer |
Q36705281 | Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor |
Search more.